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Introduction
Liver disease is still a worldwide health problem. Unfortunately, conventional or synthetic drugs used in the treatment of liver diseases are inadequate and sometimes can have serious side effects [1] . Treatment of many liver diseases is symptomatic and often disappointing, since much is still obscure about their etiology [2] . In the absence of a reliable liver protective drug in modern medicine there are a number of medicinal
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Int J Health Res, September 2010; 3(3) : 180 preparations in ayurveda recommended for the treatment of liver disorders [3] . Many formulations containing herbal extracts are sold in the Indian market for liver disorders, but management of liver disorder by a simple and precise herbal drug is still an intriguing problem. Several Indian medicinal plants have been extensively used in the Indian traditional system of medicine for the management of liver disorder [4] . In view of severe undesirable side effects of synthetic drugs, there is growing focus to follow systematic research methodology and to evaluate scientific basis for the traditional herbal medicines that are claimed to possess hepatoprotective activity.
Anisochilus Carnosus (common name: Kapurli; synonyms: Lavandula carnosa, Plectranthus strobilifer; Hindi: Panjiri-ka-patta; Telugu: Ritchu-Rodda, Omamaku; Tamil: Karpuravalli) belongs to the family Lamiaceae (Mint family). It is an annual herb, found in the Western Ghats. Stems are erect, 30-60 cm tall, robust and branched [5] . The herb has been traditionally used for the treatment of gastrointestinal disorders, cough, cold, fever and ulcer [6, 7] . Anti-ulcer activity of A. carnosus leaf extract in pylorus ligated rats has been reported [8] . To the best of our knowledge, the hepatoprotective activity of stems of the herb has not been clinically evaluated so far. In the present study, the hepatoprotective activity of the ethanolic extract of the stems of the herb against carbon tetrachloride induced hepatotoxicity in rats is reported.
Materials and Methods

Plant material
Fresh stems were collected from Sri Venkateswara University campus, Tirumala gardens of Chittor district of Andhra Pradesh, India and authentified by Asst Prof Dr K Madhava Chetty, of the Department of Botany, Sri Venkateswara University, Tirupati, Andhra Pradesh, India. Voucher specimen was deposited at Department of Pharmacognosy for further reference.
The plant material was dried under shade at room temperature, reduced to moderately coarse powder and extracted successively with 95% ethanol using soxhlet apparatus. Resultant ethanolic extract was dried under vacuum. The defatted extract of A. carnosus (EEAC) was used for the preliminary phytochemical screening and hepatoprotective studies.
Phytochemical Screening
A preliminary phytochemical screening was carried out for the extract employing the standard procedure revealed the presence of various phytoconstituents including alkaloids, flavonoids and glycosides [9, 10] .
Animals and Acute toxicity studies
Wistar albino rats of both sexes (weighing 130-160 g) were used in the present study. They were housed in clean polypropylene cages (38×23×10 cm) with not more than three animals per cage and maintained under standard laboratory condition (temperature 25±2 ºC) with dark and light cycle and provided standard pellet diet and water ad libitum. Experimental protocols for the pharmacological and toxicity studies were reviewed and approved by the Institutional Animal Ethics Committee (IAEC/PRRMCP/2006/07).
Acute toxicity study was performed for the extract as per Stair case method [11] . For the hepatoprotective studies, the amount of dose administered was adjusted on the basis of observation during the toxicity studies and accordingly extracts at two dose levels i.e., 200 and 400 mg/kg orally were administered.
Assessment of hepatoprotective activity
Thirty rats were divided randomly into five groups, each comprising of six animals. Group I (Normal control) received oral dose of 0.5% sodium CMC (1ml each) for 10 days. Group II (Toxicant control) received CCl 4 (2ml/kg, 50% in olive oil) for inducing hepatotoxicity. Group III received standard poly herbal drug 'Liv-52' (5ml/kg; p.o.) (Liv-52 syrup-Himalaya Drug Company, Bangalore, India). Group IV received
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EEAC 200 mg/kg in a day for 10 days and Group V received EEAC 400 mg/kg in a day for 10 days [12, 13] . All the animals were killed on day 11 under light ether anesthesia. The blood samples were collected separately by carotid bleeding into sterilized dry centrifuge tubes and allowed to centrifuge. The biochemical investigations were performed by using a biochemical semi-auto-analyzer. The biochemical parameters considered were: SGPT, SGOT, ALP, total bilirubin and serum protein [14, 15] .
Statistical analysis
All the values are expressed as mean±SEM and data analyzed by one-way ANOVA. At 95% confidence interval, p values less than 0.05 were considered to be significant.
Results
In CCl 4 induced hepatotoxicity, the administration of the toxicant CCl 4 showed a distinct rise in the levels of serum marker enzymes namely SGPT, SGOT, ALP and Total Bilirubin as shown in Group II of Table 1 . The drug treatment (EEAC) was carried out at two dose levels 200 and 400mg/kg, both of which along with the standard (Liv-52) treated group showed a significant reduction in the elevated enzyme levels (p<0.01). These data suggests a dose dependent hepatoprotective activity of EEAC. 
Conclusion
In the present pharmacological evaluation the whole stem extract (ethanolic) of Anisochilus Carnosus plant was extensively investigated for its hepatoprotective potential against CCl 4 induced hepatopathy. At the end of this study, a strong conclusion can be drawn that, the ethanolic extract of stems of Anisochilus Carnosus possess hepatoprotective activities more or less depending on the dose levels.
